The Ministry of Industry and Trade of RF approved Panacela Labs report developed in accordance with State Contract “Transfer of foreign development of immunotherapy drug product based on the viral vector containing genes of TL receptor and its agonist for treatment of prostate cancer and conduct of its preclinical and clinical studies”.